IFNG and breast cancer: Five human breast cancer cell lines, MDA-MB-231, MDA-MB-468, MCF-7, SKBR-3, and HCC-1419, were treated either with Th1 cytokines (IFN-γ and TNF-α), sunitinib, or both.